William H. Watson, III

VP, Business Development at Plex Pharmaceuticals

William Watson’s career stems from over 30 years in finance and has grown to provide pivotal business development strategy and implementation for Collidion, Inc. Mr. Watson has been a registered representative and registered principal with FINRA since the early 1980’s. From 2003 to 2007, he joined Brookstreet Securities as the Vice President of Corporate Finance, where he completed 21 engagements totaling over $250 million of private placements, PIPE transactions, initial public offerings, and secondary offerings for small capitalization growth companies. He has completed an additional $100 million of financing in his career for a variety of other ventures. In addition to financing activities, he also assisted in the assembly of Collidion’s scientific advisory board, interfaced with the board of directors and management, and generated key business development leads with healthcare partners. Since 2013, Mr. Watson has served on the Board of Directors of the National Investment Bankers Association.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Plex Pharmaceuticals

Plex Pharmaceuticals is a scientifically-driven company with a vision to improve the lives of patients with complex diseases and conditions.


Industries

Employees

1-10

Links